Cancer BiologybioRxivPreprint
Romaciclib, a CDK8/CDK19 inhibitor, can overcome venetoclax resistance through a combinatorial strategy
Urszula Pakulska, Marta Obacz, Jerzy Woźnicki…·Milena M. Mazan
This study shows that romaciclib combined with venetoclax overcomes venetoclax resistance in AML through synergistic apoptosis induction and suppression of resistance pathways.
3 citations